Logo

OraSure Technologies: Carrie Eglinton Manner, Nancy Gagliano, Kathleen Weber

May 26, 2022

OraSure Technologies has appointed Carrie Eglinton Manner to the role of president and CEO, replacing interim CEO Nancy Gagliano, according to a filing with US Securities and Exchange Commission. Prior to joining OraSure, Eglinton Manner served as senior VP, advanced and general diagnostic and clinical solutions at Quest Diagnostics since January 2017. Prior to Quest, she served in various leadership roles at GE Healthcare, including as president and CEO of four distinct GE Healthcare global businesses in the areas of diagnostic imaging, lab services, and medical devices.

In connection with Eglinton Manner's appointment, Gagliano will resign from her position on June 4.

In addition, Kathleen Weber, OraSure's president of molecular solutions, has also informed the company that she will resign. Pursuant to the terms of her employment, her resignation is planned for Aug. 21, 2022.

Breaking News
The Scan

Machine Learning Helps ID Molecular Mechanisms of Pancreatic Islet Beta Cell Subtypes in Type 2 Diabetes

The approach helps overcome limitations of previous studies that had investigated the molecular mechanisms of pancreatic islet beta cells, the authors write in their Nature Genetics paper.

Culture-Based Methods, Shotgun Sequencing Reveal Transmission of Bifidobacterium Strains From Mothers to Infants

In a Nature Communications study, culture-based approaches along with shotgun sequencing give a better picture of the microbial strains transmitted from mothers to infants.

Microbial Communities Can Help Trees Adapt to Changing Climates

Tree seedlings that were inoculated with microbes from dry, warm, or cold sites could better survive drought, heat, and cold stress, according to a study in Science.

A Combination of Genetics and Environment Causes Cleft Lip

In a study published in Nature Communications, researchers investigate what combination of genetic and environmental factors come into play to cause cleft lip/palate.